Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $2.79 Billion - $3.28 Billion
8,979,605 New
8,979,605 $0
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $2.93 Billion - $3.42 Billion
9,122,456 New
9,122,456 $3.34 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $40.2 Million - $45.8 Million
-135,532 Reduced 1.39%
9,590,356 $3.1 Billion
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $135 Million - $159 Million
486,011 Added 5.26%
9,725,888 $3.15 Billion
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $6.01 Million - $7.47 Million
-25,615 Reduced 0.28%
9,239,877 $2.65 Billion
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $28.6 Million - $35.5 Million
127,286 Added 1.39%
9,265,492 $2.56 Billion
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $91.5 Million - $113 Million
-412,682 Reduced 4.32%
9,138,206 $2.11 Billion
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $42.8 Million - $55.3 Million
-236,938 Reduced 2.42%
9,550,888 $2.19 Billion
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $83.1 Million - $108 Million
505,780 Added 5.45%
9,787,826 $1.83 Billion
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $36.5 Million - $48.3 Million
-279,578 Reduced 2.92%
9,282,046 $1.57 Billion
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $75.6 Million - $87.4 Million
516,719 Added 5.71%
9,561,624 $1.42 Billion
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $85.9 Million - $103 Million
629,683 Added 7.48%
9,044,905 $1.48 Billion
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $34.4 Million - $42.6 Million
289,291 Added 3.56%
8,415,222 $1.17 Billion
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $12 Million - $14.8 Million
111,832 Added 1.4%
8,125,931 $1.07 Billion
Q3 2019

Nov 07, 2019

BUY
$106.79 - $116.16 $9.01 Million - $9.8 Million
84,398 Added 1.06%
8,014,099 $896 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $24.8 Million - $28.9 Million
-223,459 Reduced 2.74%
7,929,701 $879 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $114 Million - $134 Million
-1,022,732 Reduced 11.15%
8,153,160 $1.06 Billion
Q4 2018

Feb 11, 2019

SELL
$105.9 - $118.64 $34.4 Million - $38.6 Million
-325,250 Reduced 3.42%
9,175,892 $1.06 Billion
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $2.32 Million - $2.9 Million
27,009 Added 0.29%
9,501,142 $0
Q2 2018

Aug 06, 2018

SELL
$75.7 - $86.88 $42.4 Million - $48.6 Million
-559,789 Reduced 5.58%
9,474,133 $808 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $7.06 Million - $8.33 Million
-95,112 Reduced 0.94%
10,033,922 $776 Million
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $830 Million - $890 Million
10,129,034
10,129,034 $855 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.